The LEAD Coalition has submitted its FY2027 appropriations letter to Congress. The letter, signed by 475 LEAD Coalition member organizations and allies, urges Congress to reassert our country’s non-partisan national priority to overcome Alzheimer’s disease and related disorders (AD/ADRD) by making robust appropriations for federal agencies and ensuring complete and timely expenditure of those funds for Congressionally-designated purposes. Read the letter here.
Requests include:
- HHS ASPE: A direct appropriation to support the implementation of the National Alzheimer’s Project Act
- NIH: At least $51.3 billion for the agency; an $187,210,000 increase for AD/ADRD research at NIH; $468 million for the NIH BRAIN Initiative; an increase for the NIH INCLUDE Project; limits on multi-year funding; preserve current or explore alternative model for F&A costs.
- CDC: At least $41.5 million to support the CDC Alzheimer’s Disease efforts and robust funding for the CDC National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
- ACL: An increase for the ACL Alzheimer’s Disease Program and an increase for Older Americans Act (OAA) Programs
- HRSA: At least $58.245 million for the HRSA Geriatrics workforce programs
- AHRQ: At least $500 million for AHRQ
- FDA: An increase for the FDA to keep pace with its new scientific opportunities, including $7 million for the Neurology Drug Program (NDP)
- CMS: An increase for CMS to support current and emerging AD/ADRD resources
- DOJ: An increase for the Missing Alzheimer’s Disease Alert Program